-

Endoluxe Announces Know-How Agreement With Mayo Clinic

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Endoluxe announced today it has entered into a know-how agreement with Mayo Clinic to research the use of artificial intelligence and machine learning in the fight against bladder cancer. Mayo Clinic will utilize the Endoluxe Visualization System, a wireless endoscopic “smart” camera platform, and its unique edge computing attributes, which provide AI-powered clinical insights to clinicians and can lead to better patient outcomes.

The novel Endoluxe technology platform provides clinicians real-time data and clinical insights onscreen during a surgical procedure–an important tool that no other endoscopic platform currently offers.

“Working with Mayo Clinic clinicians will further advance Endoluxe’s surgical insights capabilities. We are excited to accelerate our cutting-edge technology platform for the benefit of patients,” said Dr. Phil Zhao, Chief Medical Officer at Endoluxe.

About Endoluxe

Endoluxe is a world-class endoscopic video imaging organization based in the United States, with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices — while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at 1/4th the cost of legacy products. More information can be found at Endoluxe.com.

Contacts

Endoluxe, Inc.
Devon Bream, CEO
devon@endoluxe.com
310-529-5767

Endoluxe


Release Versions

Contacts

Endoluxe, Inc.
Devon Bream, CEO
devon@endoluxe.com
310-529-5767

Social Media Profiles
More News From Endoluxe

Endoluxe Announces Return of Founder Neal Patel, MD as CEO of Company

ATLANTA--(BUSINESS WIRE)--Endoluxe, Inc. announced today the return of founder Neal Patel, MD as CEO of the company following the departure of former CEO Devon Bream. Devon left the company to join GE Healthcare as President/General Manager, Invasive Cardiology Image Guided Therapies. Endoluxe thanked Devon for his tenure as CEO and for the significant growth he brought to the company since 2021. Devon will continue to serve as a business advisor during this transition period. Dr. Patel will ta...

Endoluxe Announces First ENT Procedures Using Endoluxe Vision System

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Endoluxe congratulates Keith Matheny, MD, FARS, of Collin County Ear Nose & Throat in Frisco, TX, for being the first ear, nose and throat (ENT) surgeon in the U.S. to use the Endoluxe Vision System for endoscopic sinus surgery. Dr. Matheny is a nationally-known innovator in the field of Otolaryngology and has developed or been involved with several game-changing technologies around the ENT space over the past two decades. After completing seven End...

Endoluxe Joins NVIDIA Inception

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Endoluxe today announced it has joined NVIDIA Inception, a program designed to support startups revolutionizing industries with artificial intelligence. Endoluxe’s first product — used in minimally invasive surgery — is a completely wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge to provide AI-powered clinical insights that can support clinicians and lead to bett...
Back to Newsroom